Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -9.84%17.94B | -7.54%17.87B | -8.45%17.63B | -9.75%17.54B | -2.65%19.9B | -4.50%19.32B | -4.58%19.25B | 0.83%19.43B | 15.21%20.44B | 27.18%20.23B |
| Transactional financial assets | 42.45%3.56B | 24.84%2.73B | 43.39%3.1B | 66.16%3B | 98.37%2.5B | 77.57%2.19B | 103.79%2.16B | 31.67%1.8B | 6.24%1.26B | 23.62%1.23B |
| Notes receivable and accounts receivable | -8.61%534.73M | -15.85%516.63M | -8.84%631.36M | 0.95%860.25M | -11.25%585.12M | 36.30%613.97M | 24.05%692.57M | 26.41%852.12M | -25.02%659.27M | -40.17%450.45M |
| -Notes receivable | -92.42%720K | ---- | ---- | -68.33%1.9M | --9.5M | --4.7M | ---- | --6M | ---- | ---- |
| -Accounts receivable | -7.23%534.01M | -15.21%516.63M | -8.84%631.36M | 1.45%858.35M | -12.69%575.62M | 35.26%609.27M | 24.05%692.57M | 25.52%846.12M | -25.02%659.27M | -40.17%450.45M |
| Other receivables (including interest and dividends) | 10.18%374.94M | 8.34%437.95M | 4.18%375.23M | 2.12%298.8M | -38.15%340.3M | -37.22%404.24M | -38.73%360.17M | -44.01%292.59M | -26.53%550.2M | -16.66%643.87M |
| -Dividend receivable | ---- | 73.01%103.19M | ---- | 0.67%121.75K | ---- | -28.14%59.64M | --120.95K | --120.95K | ---- | -26.54%83M |
| -Other receivable | ---- | -2.86%334.76M | ---- | ---- | ---- | -38.56%344.6M | ---- | -44.03%292.47M | ---- | -14.97%560.88M |
| Advance payment | -14.54%315.1M | 24.54%254.28M | 38.69%309.47M | 56.39%384.25M | 2.29%368.73M | -21.77%204.18M | -20.34%223.14M | -20.13%245.69M | 43.84%360.49M | 20.18%260.99M |
| Inventories | -6.16%2.25B | -12.96%2.15B | -13.63%2.37B | -18.50%2.44B | -13.59%2.4B | -5.60%2.47B | -5.69%2.74B | -16.95%3B | -5.38%2.77B | -11.13%2.62B |
| Assets held for sale | --33.73M | --33.73M | ---- | --327.74M | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-current assets due within one year | 47.30%28.57M | 43.81%28.58M | 41.30%28.44M | 38.52%28.36M | -19.33%19.39M | -18.74%19.87M | -16.80%20.13M | -15.12%20.47M | -8.39%24.04M | -6.58%24.46M |
| Other current assets | 21.66%262.51M | 30.00%274.37M | 50.77%289.19M | 44.98%204.54M | 41.28%215.77M | 29.43%211.05M | 6.50%191.81M | -13.30%141.08M | -66.96%152.73M | -78.32%163.06M |
| Total current assets | -3.89%25.3B | -4.49%24.29B | -3.57%24.73B | -2.74%25.08B | 0.39%26.32B | -0.74%25.43B | -0.50%25.65B | -0.61%25.78B | 8.23%26.22B | 14.54%25.63B |
| Non Current assets | ||||||||||
| Other equity investment | 25.80%4.06B | 47.74%4.33B | 29.04%3.66B | 28.40%3.75B | 3.16%3.23B | -2.11%2.93B | -2.06%2.83B | 2.67%2.92B | 11.29%3.13B | -5.95%2.99B |
| Other non-current financial assets | -87.48%74.88M | -87.39%74.88M | -88.63%67.57M | -88.54%67.57M | 2.48%598.17M | 2.50%593.69M | 5.19%594.17M | 5.22%589.74M | 1,221.61%583.71M | 1,211.48%579.23M |
| Investment real estate | -12.89%88.67M | -12.76%90.74M | -8.32%97.38M | -8.16%99.59M | -8.00%101.8M | -7.84%104.01M | -7.69%106.22M | -7.54%108.43M | -7.40%110.64M | -7.27%112.86M |
| Long-term equity investment | 18.04%1.76B | 123.04%1.79B | 117.02%1.82B | 117.16%1.81B | 34.13%1.49B | -29.40%801.88M | -31.25%836.34M | -29.86%831.61M | -13.41%1.11B | -12.58%1.14B |
| Long term receivable account | -74.50%9.45M | -72.26%11.41M | -76.79%18.62M | -30.52%21.91M | 39.10%37.05M | 49.84%41.13M | 42.90%80.19M | -44.43%31.54M | -51.62%26.64M | -51.54%27.45M |
| Fixed assets | ---- | -5.23%13.22B | ---- | ---- | ---- | 1.88%13.95B | ---- | 4.95%14.32B | ---- | -6.46%13.69B |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | --29.78K | ---- | ---- | ---- | ---- |
| Constru in process | ---- | 53.85%196.11M | ---- | ---- | ---- | -54.62%127.47M | ---- | -88.96%51.58M | ---- | -57.68%280.91M |
| Intangible assets | 6.70%3.28B | 4.31%3.32B | 0.90%3.25B | 0.53%3.27B | -6.24%3.08B | -4.02%3.18B | -3.83%3.22B | -3.64%3.26B | -11.87%3.28B | -11.89%3.31B |
| Goodwill | -2.14%153.69M | -1.84%154.17M | -1.22%155.13M | -1.22%155.13M | -1.21%157.05M | -1.21%157.05M | -1.21%157.05M | -1.21%157.05M | -1.19%158.97M | -1.19%158.97M |
| Long deferred expense | -8.87%702.21M | -13.01%701.13M | -13.36%743.03M | -11.85%802.56M | -12.79%770.53M | -12.62%806.04M | -9.97%857.63M | -9.79%910.42M | -8.06%883.49M | -7.32%922.46M |
| Deferred tax assets | -40.07%103.56M | -19.50%166.71M | -16.22%175.77M | -13.33%188.38M | -75.83%172.82M | -71.03%207.09M | -1.51%209.81M | -0.23%217.36M | 457.65%714.97M | 468.32%714.97M |
| Usufruct assets | -14.61%5.38B | -13.47%5.59B | -13.11%5.86B | -15.10%6.02B | -13.11%6.3B | -15.11%6.46B | -13.29%6.75B | -13.67%7.1B | -14.62%7.25B | -11.90%7.61B |
| Other non current assets | 190.19%643.54M | 78,578.67%467.41M | 42,320.88%252.01M | 275,746.22%1.64B | 37,229.35%221.76M | 13.73%594.07K | -32.57%594.07K | -37.61%594.07K | -99.62%594.07K | -99.58%522.38K |
| Total non current assets | -0.27%29.6B | 2.55%30.11B | -1.45%29.4B | 2.57%31.27B | -4.74%29.68B | -6.92%29.36B | -4.76%29.83B | -4.31%30.48B | -6.02%31.16B | -6.71%31.54B |
| Total assets | -1.98%54.9B | -0.72%54.4B | -2.43%54.13B | 0.14%56.35B | -2.40%56B | -4.15%54.79B | -2.84%55.47B | -2.65%56.27B | 0.00%57.38B | 1.75%57.17B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -36.43%586.33M | -61.49%532.46M | -49.42%565.05M | -26.19%549.01M | 17.51%922.31M | 80.72%1.38B | 87.72%1.12B | -9.38%743.86M | -29.41%784.85M | -24.83%764.97M |
| Notes payable and accounts payable | -10.29%5.63B | -16.66%5.23B | -15.15%5.15B | -5.10%6.56B | 1.40%6.28B | 3.82%6.28B | -1.14%6.07B | 10.55%6.91B | 6.57%6.19B | 7.91%6.05B |
| -Notes payable | -2.17%1.9B | -32.76%1.08B | -30.98%724.71M | -23.80%1.1B | 33.79%1.94B | 6.67%1.6B | 5.00%1.05B | 45.00%1.45B | 93.33%1.45B | 637.64%1.5B |
| -Accounts payable | -13.92%3.73B | -11.16%4.16B | -11.84%4.42B | -0.14%5.45B | -8.50%4.34B | 2.88%4.68B | -2.34%5.02B | 3.99%5.46B | -6.29%4.74B | -15.79%4.55B |
| Contract liabilities | -1.07%6.22B | 0.65%6.07B | -2.06%6.38B | -1.25%6.45B | -1.17%6.29B | -0.55%6.03B | 3.02%6.52B | 4.36%6.53B | -1.45%6.36B | 3.91%6.06B |
| Advance receipts | 1,047.97%1.11B | -14.94%100.11M | -11.68%112.63M | -17.43%118.25M | -20.28%96.29M | -1.31%117.68M | -1.37%127.53M | 29.88%143.21M | -19.15%120.78M | -6.99%119.25M |
| Salaries payable | -2.99%471.39M | -0.77%433.31M | -1.66%361.75M | -3.16%564.73M | -20.16%485.89M | -17.96%436.69M | -18.86%367.85M | -11.04%583.18M | -1.73%608.61M | 2.24%532.3M |
| Taxs payable | -48.01%322.79M | -13.00%353.8M | -8.41%452.3M | -14.94%438.19M | 43.04%620.86M | -1.05%406.66M | -3.30%493.83M | 4.60%515.13M | 19.77%434.04M | 29.96%410.97M |
| Other payable (including interest and dividends) | -3.81%4.8B | -2.51%5.18B | -9.36%4.8B | 0.04%5.32B | -11.55%4.99B | -8.02%5.31B | -6.20%5.29B | -10.64%5.32B | -7.50%5.64B | -8.08%5.77B |
| -Dividend payable | -35.99%39.81M | 84.14%512.06M | -4.01%132.01M | -15.25%132.01M | 2.42%62.19M | 1.85%278.08M | 132.87%137.52M | 136.70%155.76M | 17.37%60.72M | -14.51%273.04M |
| -Other payable | ---- | -7.30%4.67B | ---- | ---- | ---- | -8.51%5.03B | ---- | -12.28%5.16B | ---- | -7.74%5.5B |
| Hold and for sell liabilities | ---- | ---- | ---- | --419.72M | ---- | ---- | ---- | ---- | ---- | ---- |
| Non current liabilities due within one year | -7.41%1.25B | -0.90%1.32B | -14.55%1.24B | -19.70%1.2B | -2.77%1.35B | -9.75%1.33B | -0.51%1.45B | 2.42%1.49B | -24.37%1.39B | -26.69%1.48B |
| Other current liabilities | -6.20%3.2B | -5.85%3.19B | -6.13%3.22B | -5.47%3.24B | -0.51%3.41B | 0.74%3.39B | 0.08%3.43B | -0.09%3.43B | -0.07%3.43B | 41.20%3.37B |
| Total current liabilities | -3.50%23.59B | -9.21%22.42B | -10.40%22.28B | -3.15%24.86B | -2.08%24.45B | 0.54%24.69B | 0.75%24.86B | 0.94%25.67B | -3.53%24.97B | 1.88%24.56B |
| Current liabilities | ||||||||||
| Long term loan | -1.91%1.75B | 1.22%1.78B | -11.57%1.65B | -8.77%1.68B | -12.72%1.78B | -17.73%1.76B | -13.63%1.87B | -9.30%1.84B | 14.26%2.04B | 26.71%2.14B |
| Long term account payable | ---- | 0.00%20.34M | ---- | ---- | ---- | 0.00%20.34M | ---- | 0.00%20.34M | ---- | 0.00%20.34M |
| Long term salaries pay | 9.42%338.38M | 9.42%338.38M | 9.42%338.38M | 9.42%338.38M | 10.73%309.26M | 10.73%309.26M | 10.73%309.26M | 10.73%309.26M | 7.58%279.29M | 7.58%279.29M |
| Specific account payable | ---- | 0.00%8.98M | ---- | ---- | ---- | 0.00%8.98M | ---- | 0.00%8.98M | ---- | 0.00%8.98M |
| Estimate liabilities | 16.27%146.12M | 18.88%149.45M | 0.57%126.57M | 12.36%142.87M | -4.92%125.68M | -5.11%125.72M | -7.25%125.86M | -6.33%127.15M | 6.58%132.17M | 8.18%132.49M |
| Deferred tax liabilities | 17.36%1.22B | 60.57%1.34B | 41.88%1.14B | 49.23%1.24B | -25.94%1.04B | -38.36%834.49M | -0.92%802.6M | 0.18%828.41M | 75.23%1.4B | 53.78%1.35B |
| Long term deferred income | -12.51%122.79M | -13.06%124.13M | -13.88%124.66M | -12.78%127.97M | -12.68%140.35M | -11.73%142.79M | -11.65%144.75M | -10.52%146.71M | -11.95%160.73M | -11.84%161.76M |
| Lease liabilities | -13.53%6.09B | -13.01%6.25B | -12.22%6.57B | -12.71%6.72B | -12.05%7.04B | -12.15%7.18B | -10.36%7.48B | -13.35%7.7B | -12.02%8.01B | -11.62%8.18B |
| Total non current liabilities | -7.40%9.69B | -3.59%10.01B | -7.29%9.98B | -6.43%10.27B | -13.15%10.47B | -15.38%10.39B | -9.78%10.76B | -11.09%10.98B | -1.89%12.06B | -1.15%12.27B |
| Total liabilities | -4.67%33.29B | -7.55%32.43B | -9.46%32.26B | -4.13%35.13B | -5.68%34.92B | -4.77%35.08B | -2.68%35.63B | -2.99%36.65B | -3.00%37.02B | 0.85%36.83B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B | 0.00%1.78B |
| Capital reserve funds | 4.06%3.13B | 4.08%3.13B | 0.41%3.11B | -2.31%3.02B | -1.29%3.01B | -1.29%3.01B | 1.40%3.09B | 0.72%3.09B | 0.00%3.05B | 0.00%3.05B |
| Surplus reserve funds | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B | 0.00%1.46B |
| Retained profit | 8.32%12.01B | 23.46%12.03B | 25.35%12.39B | 13.95%11.04B | 14.31%11.09B | 0.62%9.75B | 0.98%9.88B | 1.95%9.69B | 11.67%9.7B | 10.54%9.69B |
| Other composite income | -28.25%1.43B | -7.83%1.63B | -33.62%1.13B | 33.38%2.35B | 2.33%1.99B | -4.09%1.77B | -4.11%1.7B | 1.67%1.76B | 13.11%1.95B | -7.67%1.85B |
| Specific reserves | 0.00%11.02M | -6.77%11.02M | -6.77%11.02M | -9.07%11.02M | -9.07%11.02M | -2.47%11.82M | -2.47%11.82M | 0.00%12.12M | -6.19%12.12M | -6.19%12.12M |
| Shareholders equity without minority interests | 2.49%19.83B | 12.76%20.05B | 10.86%19.87B | 10.48%19.66B | 7.76%19.35B | -0.31%17.78B | 0.37%17.93B | 1.34%17.8B | 7.41%17.96B | 4.51%17.84B |
| Minority interests | 2.37%1.78B | -0.69%1.92B | 3.99%2B | -14.90%1.55B | -27.70%1.73B | -22.50%1.93B | -26.79%1.92B | -25.82%1.82B | -3.69%2.4B | -3.63%2.49B |
| Total shareholder equity | 2.48%21.61B | 11.45%21.97B | 10.19%21.87B | 8.12%21.21B | 3.58%21.08B | -3.03%19.72B | -3.11%19.85B | -1.99%19.62B | 5.97%20.36B | 3.43%20.33B |
| Total liabilityies and equity | -1.98%54.9B | -0.72%54.4B | -2.43%54.13B | 0.14%56.35B | -2.40%56B | -4.15%54.79B | -2.84%55.47B | -2.65%56.27B | 0.00%57.38B | 1.75%57.17B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.